Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Heinzerling

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Drug and Alcohol Dependence|June 4, 2018
Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trialMarisa Briones, Steven Shoptaw, Ryan Cook, et al.
Progress in Community Health Partnerships : Research, Education, and Action|January 16, 2018
Implementing the Chronic Care Model for Opioid and Alcohol Use Disorders in Primary CareKatherine E Watkins, Allison J Ober, Karen Lamp, et al.
Drug and Alcohol Dependence|July 14, 2017
Ibudilast may improve attention during early abstinence from methamphetamineJ Brandon Birath, Marisa Briones, Stephanie Amaya, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 25, 2015
The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory StudyLara A Ray, Spencer Bujarski, Kelly E Courtney, et al.
BMC Family Practice|December 23, 2017
Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: findings from the SUMMIT studyAllison J Ober, Katherine E Watkins, Sarah B Hunter, et al.
JAMA Internal Medicine|August 29, 2017
Collaborative Care for Opioid and Alcohol Use Disorders in Primary Care: The SUMMIT Randomized Clinical TrialKatherine E Watkins, Allison J Ober, Karen Lamp, et al.
JAMA|August 31, 2023
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical TrialCharles L Raison, Gerard Sanacora, Joshua Woolley, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Drug and Alcohol Dependence|June 4, 2018
Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trialMarisa Briones, Steven Shoptaw, Ryan Cook, et al.
Progress in Community Health Partnerships : Research, Education, and Action|January 16, 2018
Implementing the Chronic Care Model for Opioid and Alcohol Use Disorders in Primary CareKatherine E Watkins, Allison J Ober, Karen Lamp, et al.
Drug and Alcohol Dependence|July 14, 2017
Ibudilast may improve attention during early abstinence from methamphetamineJ Brandon Birath, Marisa Briones, Stephanie Amaya, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 25, 2015
The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory StudyLara A Ray, Spencer Bujarski, Kelly E Courtney, et al.
BMC Family Practice|December 23, 2017
Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: findings from the SUMMIT studyAllison J Ober, Katherine E Watkins, Sarah B Hunter, et al.
JAMA Internal Medicine|August 29, 2017
Collaborative Care for Opioid and Alcohol Use Disorders in Primary Care: The SUMMIT Randomized Clinical TrialKatherine E Watkins, Allison J Ober, Karen Lamp, et al.
JAMA|August 31, 2023
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical TrialCharles L Raison, Gerard Sanacora, Joshua Woolley, et al.
Pageof 2